Table 1.
Variable | Group I (bilateral orchidectomy) | Group II (degarelix) | P |
---|---|---|---|
Number of patients | 33 | 27 | |
Age, years, mean (SD) | 67.73 (7.24) | 67.80 (7.73) | 0.973* |
Gleason Groups, n (%) | 0.027** | ||
Group 1 | 6 (18.2) | 2 (7.4) | |
Group 2 | 3 (9.1) | 2 (7.4) | |
Group 3 | 6 (18.2) | 15 (55.6) | |
Group 4 | 10 (30.3) | 2 (7.4) | |
Group 5 | 8 (24.2) | 6 (22.2) | |
Serum PSA level (ng/mL), n (%) | 0.912** | ||
<20 | 4 (12.1) | 4 (14.8) | |
20–50 | 5 (15.2) | 3 (11.1) | |
>50 | 24 (72.7) | 20 (74.1) | |
Symptoms at presentation, n (%) | |||
LUTS | 33 (100) | 25 (92.5) | 0.492*** |
Bone pain | 21 (63.6) | 15 (55.6) | 0.791 |
Obstructive uropathy | 6 (18.2) | 0 | 0.024 |
*Chi-square test, **Monte Carlo correlation, ***Fisher’s exact correlation.